Influenza virus (IV) infection currently poses a serious and continuing threat to the global public health. Developing effective prevention strategies is important to defend against infection and spread of IV. Here, we developed a triple-protective nanoshield against IV infection in the lungs, formed by self-assembling DSPE-PEG amphiphilic polymers encapsulating the flu-preventive antiviral drug Arbidol internally. The preventive effect of the nanoshield against virus infection includes increasing the viscosity in the surrounding environment to physically defend against viral entry, forming a hydrated layer to block the interaction between viruses and cells, and inhibiting virus replication. Our finding suggested that a single inhalation of the nanoshield provides effective protection against IV infection for at least 8 h. Thus, this nanoshield may be a potential pandemic protection agent against IV, especially in viral environments, where no prophylactic or therapeutic measures are available.
An Inhalable Nanoshield for Effective Prevention of Influenza Virus Infections.
Jing Li,Xue-Hui Shi,Dandan Fu,Lei Du,Bo Tang,Jian Ao,Ai-Xin Ma,Yi-Ning Hou,Zhi-Gang Wang,Shu-Lin Liu,Dai-Wen Pang
Published 2024 in ACS Nano
ABSTRACT
PUBLICATION RECORD
- Publication year
2024
- Venue
ACS Nano
- Publication date
2024-09-24
- Fields of study
Medicine, Materials Science, Chemistry
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-37 of 37 references · Page 1 of 1
CITED BY
Showing 1-3 of 3 citing papers · Page 1 of 1